Joinn Laboratories(China)Co.,Ltd. (HKG:6127)

Market Cap	12.07B
Revenue (ttm)	2.15B
Net Income (ttm)	78.83M
Shares Out	n/a
EPS (ttm)	0.11
PE Ratio	153.14
Forward PE	48.98
Dividend	0.18 (1.81%)
Ex-Dividend Date	Jun 28, 2024

Volume	3,232,820
Average Volume	4,666,283
Open	9.98
Previous Close	9.96
Day's Range	9.74 - 10.02
52-Week Range	6.31 - 17.60
Beta	0.66
RSI	40.37
Earnings Date	Apr 28, 2025

About HKG:6127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I cli...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,510
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6127

Financial Performance

In 2024, HKG:6127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.

Financial numbers in CNY